| mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |